Downregulation of SETD5 Suppresses the Tumorigenicity of Hepatocellular Carcinoma Cells
Sign Up to like & getrecommendations! Published in 2022 at "Molecules and Cells"
DOI: 10.14348/molcells.2022.0009
Abstract: Hepatocellular carcinoma (HCC) is an aggressive and incurable cancer. Although understanding of the molecular pathogenesis of HCC has greatly advanced, therapeutic options for the disease remain limited. In this study, we demonstrated that SETD5 expression… read more here.
Keywords: setd5; hepatocellular carcinoma; cells downregulation; hcc cells ... See more keywords